News | March 28, 2022
Tata Capital Healthcare Fund II raises Rs 955 crore
The fund will take equity positions in India-focused healthcare and life sciences-related companies
The fund will take equity positions in India-focused healthcare and life sciences-related companies
These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training
U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current USFDA approved or emergency use authorized-vaccines
It recognizes the company's commitment to safeguarding sensitive data, protecting patient information
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
Recommendation is based on pivotal data from the phase III POLARIX study
A staggering 65% of the TB cases in India are in the 15-45 age group
Organizations to combine expertise to further develop AI/ML-powered drug design platform, delivering precise, effective, and life-changing medicines at scale
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Subscribe To Our Newsletter & Stay Updated
